The relevance of the urinary concentration of ephedrines in anti-doping analysis: Determination of pseudoephedrine, cathine, and ephedrine after administration of over-the-counter medicaments

Therapeutic Drug Monitoring

Volumn 31, Issue 4, 2009, Pages 520-526

  Strano Rossi, Sabina ^a   Leone, Daniele ^a   Torre, Xavier De La ^a   Botrè, Francesco ^a,b  

^a Laboratorio Antidoping   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Doping analysis; Drug monitoring; Ephedrines; Mass spectrometry; Pharmacokinetics; Urine analysis

Indexed keywords

CETIRIZINE; CREATININE; DEUTERIUM; EPHEDRINE; FIENAMINE; METHYLEPHEDRINE; NON PRESCRIPTION DRUG; NORPSEUDOEPHEDRINE; PSEUDOEPHEDRINE PLUS TRIPROLIDINE; TRIMETHYLSILYL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DERIVATIZATION; DOPING; DRUG DETERMINATION; DRUG SELF ADMINISTRATION; DRUG URINE LEVEL; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; LIQUID LIQUID EXTRACTION; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RELATIVE DENSITY; REPEATED DRUG DOSE; SINGLE DRUG DOSE; STANDARD; SUSTAINED RELEASE FORMULATION; URINALYSIS; VALIDATION STUDY;

ADULT; DOPING IN SPORTS; EPHEDRINE; FEMALE; HUMANS; MALE; NONPRESCRIPTION DRUGS; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; SUBSTANCE ABUSE DETECTION;

EID: 68449101176     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181ac6006     Document Type: Article

References (8)

1. The World Anti-Doping Code. The 2008 Prohibited List International Standard. Montreal, Canada: World Anti-Doping Agency; 2008. Also available at www.wada-ama.org/rtecontent/document/2008-List-En.pdf. Accessed October 10, 2008.
2. Tseng YL, Shieh MH, Kuo FH. Metabolites of ephedrines in human urine after administration of a single therapeutic dose. Forensic Sci Int. 2006;157:149-155.
3. Chester N, Mottram DR, Reilly T, et al. Elimination of ephedrines in urine following multiple dosing: The consequences for athletes, in relation to doping control. Br J Clin Pharmacol. 2004;57:62-67.
4. Tseng YL, Hsu HR, Kuo FH, et al. Ephedrines in over-the-counter cold medicines and urine specimens collected during sport competitions. J Anal Toxicol. 2003;27:359-365.
5. Lai CM, Stoll RG, Look ZM, et al. Urinary excretion of chlorpheniramine and pseudoephedrine in humans. J Pharm Sci. 1979;68:1243-1246.
6. Haller CA, Jacob P III, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 2002;71:421-432.
7. Forsdahl G, Gmeiner G. Investigation of the silylation of ephedrines using N-methyl-N-trimethylsilyl-trifluoroacetamide. J Chromatogr B. 2004;811:201-208.
8. De la Torre R, Farré M, Navarro M, et al. Clinical pharmacokinetics of amphetamine and relates substances. Clin Pharmacokinet. 2004;43:157-185.